: (21) 96795 3480O estudo Hepatite: quem ama Cuida baseou-se nas seguintes obras referenciais:
1. Hepatitis C [https://www.who.int/news-room/fact-sheets/detail/hepatitis-c]
2. Lingala S, Ghany MG: Natural History of Hepatitis C. Gastroenterol Clin North Am 2015, 44(4):717-734.
3. Falade-Nwulia O, Suarez-Cuervo C, Nelson DR, Fried MW, Segal JB, Sulkowski MS: Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection: A Systematic Review. Ann Intern Med 2017, 166(9):637-648.
4. Global health sector strategy on viral hepatitis 2016–2021 [https://apps.who.int/iris/bitstream/handle/10665/246177/WHO-HIV-2016.06-eng.pdf?sequence=1&isAllowed=y]
5. Krassenburg LAP, Maan R, Ramji A, Manns MP, Cornberg M, Wedemeyer H, de Knegt RJ, Hansen BE, Janssen HLA, de Man RA et al: Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity. J Hepatol 2020.
6. WHO: Recommendations and guidance on hepatitis C virus self-testing. In.; 2022.
7. Kondili LA, Buti M, Riveiro-Barciela M, Maticic M, Negro F, Berg T, Craxi A: Impact of the COVID-19 pandemic on hepatitis B and C elimination: An EASL survey. JHEP Rep 2022, 4(9):100531.
8. WHO: Number of Countries Adopting HIV Self-Testing Policies Rises Sharply. In.; 2017.
9. Peiper NC, Shamblen S, Gilbertson A, Guest G, Kopp M, Guy L, Rose MR: Acceptability of a HIV self-testing program among people who use illicit drugs. Int J Drug Policy 2022, 103:103613.
10. Witzel TC, Rodger AJ, Burns FM, Rhodes T, Weatherburn P: HIV Self-Testing among Men Who Have Sex with Men (MSM) in the UK: A Qualitative Study of Barriers and Facilitators, Intervention Preferences and Perceived Impacts. PLoS One 2016, 11(9):e0162713.
11. General characteristics of the population [https://www.ibge.gov.br/en/statistics/social/population.html]
12. BRAZIL: Boletim Epidemiológico de Hepatites Virais [Epidemiological report on virus hepatitis]. In.; 2020.
13. Portari-Filho LH, Alvares-da-Silva MR, Gonzalez A, Ferreira AP, Villela-Nogueira CA, Mendes-Correa MC, Lima JM, Lopes EP, Brandao CE, Ivantes C et al: How are HCV-infected patients being identified in Brazil: a multicenter study. Braz J Infect Dis 2019, 23(1):34-39.
14. Perazzo H, Pacheco AG, Luz PM, Castro R, Hyde C, Fittipaldi J, Rigolon C, Cardoso SW, Grinsztejn B, Veloso VG: Age-standardized mortality rates related to viral hepatitis in Brazil. BMC Infect Dis 2017, 17(1):527.
15. Perazzo H, Pacheco AG, De Boni R, Luz PM, Fittipaldi J, Cardoso SW, Grinsztejn B, Veloso VL: Age-Standardized Mortality Rates Related to Cirrhosis in Brazil from 2000 to 2012: A nationwide Analysis. Ann Hepatol 2017, 16(2):269-278.
16. Castro Filho EC, Piedade J, Castro R, Luz PM, Fernandes F, Grinsztejn B, Veloso VG, Pereira GH, Perazzo H: Effectiveness of direct-acting agents for chronic hepatitis C treatment in South America: A systematic review and meta-analysis. J Viral Hepat 2020, 27(12):1396-1407.
17. Carvalho-Louro DM, Soares EB, Trevizoli JE, Marra TMG, da Cunha ALR, Rodrigues MP, Carvalho-Furtado ACL, Dos Santos BTA, de Assis da Rocha Neves F: Hepatitis C screening, diagnosis, and cascade of care among people aged > 40 years in Brasilia, Brazil. BMC Infect Dis 2020, 20(1):114.
18. Jin F, Dore GJ, Matthews G, Luhmann N, Macdonald V, Bajis S, Baggaley R, Mathers B, Verster A, Grulich AE: Prevalence and incidence of hepatitis C virus infection in men who have sex with men: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol 2021, 6(1):39-56.
19. Irvin R, Gamble T, Malone J, Wang Z, Wilson E, Hughes JP, Farley J, Mayer KH, Del Rio C, Batey DS et al: HPTN 078: High Prevalence of HCV Antibodies Among Urban U.S. Men Who Have Sex with Men (MSM) Independent of HIV Status. Clin Infect Dis 2020.
20. Facente SN, Grinstein R, Bruhn R, Kaidarova Z, Wilson E, Hecht J, Burk K, Grebe E, Morris MD: Hepatitis C prevalence and key population size estimate updates in San Francisco: 2015 to 2019. PLoS One 2022, 17(5):e0267902.
21. Zheng Y, Ying M, Zhou Y, Lin Y, Ren J, Wu J: Global Burden and Changing Trend of Hepatitis C Virus Infection in HIV-Positive and HIV-Negative MSM: A Systematic Review and Meta-Analysis. Front Med (Lausanne) 2021, 8:774793.
22. Cocchetti C, Romani A, Mazzoli F, Ristori J, Lagi F, Meriggiola MC, Motta G, Pierdominici M, Bartoloni A, Vignozzi L et al: Prevalence and Correlates of Sexually Transmitted Infections in Transgender People: An Italian Multicentric Cross-Sectional Study. J Clin Med 2022, 11(10).
23. Hernandez CJ, Trujillo D, Turner CM, Sicro S, Meza J, Bella M, Daza E, Torres F, McFarland W, Wilson EC: Reaching trans women in San Francisco for efforts to eliminate hepatitis C. J Viral Hepat 2021, 28(9):1325-1328.
24. Silva BGD, Ferreira LH, Ribeiro CEL, Raboni SM: HIV, syphilis, hepatitis B and C in key populations: results of a 10-year cross-sectional study, Southern Brazil. Einstein (Sao Paulo) 2022, 20:eAO6934.
25. Adu PA, Rossi C, Binka M, Wong S, Wilton J, Wong J, Butt ZA, Bartlett S, Jeong D, Pearce M et al: HCV reinfection rates after cure or spontaneous clearance among HIV-infected and uninfected men who have sex with men. Liver Int 2021, 41(3):482-493.
26. Recently acquired and early chronic hepatitis C in MSM: Recommendations from the European treatment network for HIV, hepatitis and global infectious diseases consensus panel. AIDS 2020, 34(12):1699-1711.
27. Rockstroh JK, Boesecke C: Hepatitis C Virus Treatment as Prevention: Challenges and Opportunities in Men Who Have Sex With Men. J Infect Dis 2020, 222(Suppl 9):S782-S788.
28. Hoagland B, Torres TS, Bezerra DRB, Geraldo K, Pimenta C, Veloso VG, Grinsztejn B: Telemedicine as a tool for PrEP delivery during the COVID-19 pandemic in a large HIV prevention service in Rio de Janeiro-Brazil. Braz J Infect Dis 2020, 24(4):360-364.
29. Hoagland B, Torres TS, Bezerra DRB, Benedetti M, Pimenta C, Veloso VG, Grinsztejn B: High acceptability of PrEP teleconsultation and HIV self-testing among PrEP users during the COVID-19 pandemic in Brazil. Braz J Infect Dis 2021, 25(1):101037.
30. Majam M, Fischer A, Ivanova Reipold E, Rhagnath N, Msolomba V, Lalla-Edward ST: A Lay-User Assessment of Hepatitis C Virus Self-Testing Device Usability and Interpretation in Johannesburg, South Africa. Diagnostics (Basel) 2021, 11(3).
31. Tonen-Wolyec S, Djang’eing’a RM, Batina-Agasa S, Kayembe Tshilumba C, Muwonga Masidi J, Hayette MP, Belec L: Self-testing for HIV, HBV, and HCV using finger-stick whole-blood multiplex immunochromatographic rapid test: A pilot feasibility study in sub-Saharan Africa. PLoS One 2021, 16(4):e0249701.
32. Kimble MM, Stafylis C, Treut P, Saab S, Klausner JD: Clinical evaluation of a hepatitis C antibody rapid immunoassay on self-collected oral fluid specimens. Diagn Microbiol Infect Dis 2019, 95(2):149-151.
33. Reipold EI, Farahat A, Elbeeh A, Soliman R, Aza EB, Jamil MS, Johnson CC, Shiha G, Easterbrook P: Usability and acceptability of self-testing for hepatitis C virus infection among the general population in the Nile Delta region of Egypt. BMC Public Health 2021, 21(1):1188.
34. Xu W, Reipold EI, Zhao P, Tang W, Tucker JD, Ong JJ, Wang J, Easterbrook P, Johnson CC, Jamil MS et al: HCV Self-Testing to Expand Testing: A Pilot Among Men Who Have Sex With Men in China. Front Public Health 2022, 10:903747.
35. Reipold EI, Nguyen TTV, Shiha G, Stvilia K, Monroe-Wise A, Wang C, Jamil M, Johnson C, Easterbrook P: SELF-TESTING FOR HCV: MULTICOUNTRY EVIDENCE ON USABILITY AND ACCEPTABILITY. In: Conference on Retroviruses and Opportunistic Infections. Boston; 2021.
36. Nguyen LT, Nguyen VTT, Le Ai KA, Truong MB, Tran TTM, Jamil MS, Johnson C, Reipold EI, Easterbrook P, Park K: Acceptability and Usability of HCV Self-Testing in High Risk Populations in Vietnam. Diagnostics (Basel) 2021, 11(2).
37. Fajardo E, Watson V, Kumwenda M, Usharidze D, Gogochashvili S, Kakhaberi D, Giguashvili A, Johnson CC, Jamil MS, Dacombe R et al: Usability and acceptability of oral-based HCV self-testing among key populations: a mixed-methods evaluation in Tbilisi, Georgia. BMC Infect Dis 2022, 22(1):510.
38. Perazzo H, Villela-Nogueira C, Gomes M, Daher A, Valle C, Ferreira A, Almeida E, Cardoso S, Grinsztejn B, Veloso V: Usability and acceptability of HCV Self-Testing in the general population from Brazil In: 30th Conference on Retroviruses and Opportunistic Infections (CROI). Washington (Seattle); 2023.
39. de Andrade AA, Silva A, Carneiro M, Teles SA, Martins RMB: Hepatitis C prevalence among men who have sex with men in Central Brazil. Braz J Infect Dis 2019, 23(4):271-273.
40. Veloso VG, Caceres CF, Hoagland B, Moreira RI, Vega-Ramirez H, Konda KA, Leite IC, Bautista-Arredondo S, Vinicius de Lacerda M, Valdez Madruga J et al: Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study. Lancet HIV 2023, 10(2):e84-e96.
41. Puga MA, Bandeira LM, Pompilio MA, Croda J, Rezende GR, Dorisbor LF, Tanaka TS, Cesar GA, Teles SA, Simionatto S et al: Prevalence and Incidence of HCV Infection among Prisoners in Central Brazil. PLoS One 2017, 12(1):e0169195.
42. De Boni RB, Veloso VG, Fernandes NM, Lessa F, Correa RG, Lima RS, Cruz M, Oliveira J, Nogueira SM, de Jesus B et al: An Internet-Based HIV Self-Testing Program to Increase HIV Testing Uptake Among Men Who Have Sex With Men in Brazil: Descriptive Cross-Sectional Analysis. J Med Internet Res 2019, 21(8):e14145.
43. Xu X, Grossetta Nardini HK, Ruger JP: Micro-costing studies in the health and medical literature: protocol for a systematic review. Syst Rev 2014, 3:47.
44. Perazzo H, Jorge MJ, Silva JC, Avellar AM, Silva PS, Romero C, Veloso VG, Mujica-Mota R, Anderson R, Hyde C et al: Micro-costing analysis of guideline-based treatment by direct-acting agents: the real-life case of hepatitis C management in Brazil. BMC Gastroenterol 2017, 17(1):119.